In the CNS PNET cohort, CTNNB1 nuclear cases contained a higher proportion of males (male: female ratio 4 : 1 compared with 0.6 : 1 in non-nuclear), and displayed a higher 5-year survival rate (30% compared with 13%) than the non-nuclear cases. Here, CTNNB1 is linked to primitive neuroectodermal tumor.